🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In six communities we will seek out households where someone who has a hist...
Status
Completed
Location
Otara Health Inc
Start Date
2001-07
Trial ID
NCT00437541
Treatments Being Tested
The trial is an investigator-initiated, double-blind, randomized, placebo-c...
Status
Completed
Location
Frederiksberg University Hospital
Start Date
2011-11
Trial ID
NCT01459952
Treatments Being Tested
The primary objective of this study is to determine the effect of an encaps...
Status
Completed
Location
Institute for Social medicine, Epidemiology & Health Economics
Start Date
2008-09
Trial ID
NCT00778648
Treatments Being Tested
The purpose of this research study is to determine whether a functional fib...
Status
Completed
Location
University of Florida
Start Date
2009-10
Trial ID
NCT01137760
Treatments Being Tested
We hypothesize the herbal preparation will enhance the preschoolers' immune...
Status
Completed
Location
Cleveland Clinic Foundation
Start Date
2006-01
Trial ID
NCT00231218
Treatments Being Tested
This prospective, multicenter, observational post-market clinical follow-up...
Status
Not Yet Recruiting
Location
Multiples facilities
Start Date
2026-10-15
Trial ID
NCT07625683
The aim of the study is to assess the safety of inhaled SNG001 and the abil...
Status
Completed
Location
Celerion
Start Date
2018-01-29
Trial ID
NCT03570359
Treatments Being Tested
The primary goal of this study is to observe the impact of the IDP® Supplem...
Status
Recruiting
Location
People Science, Inc.
Start Date
2025-12-05
Trial ID
NCT07431840
Treatments Being Tested
Background: The objective of corneal collagen crosslinking (CXL) is to incr...
Status
Unknown
Location
Instituto de oftalmología conde de Valenciana
Start Date
2018-02-01
Trial ID
NCT03760770
Treatments Being Tested
The main purpose of this study is to evaluate the safety of nasal glucagon ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2013-03
Trial ID
NCT02778100
Treatments Being Tested